Millennium Management’s CureVac CVAC Stock Holding History

Millennium Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-118,300	Closed	-$402K	–	6156
2024 Q2	$402K	Buy	+118,300	New	+$387K	﹤0.01%	4733
2023 Q3	–	Sell	-15,300	Closed	-$159K	–	6195
2023 Q2	$159K	Buy	+15,300	New	+$137K	﹤0.01%	5206
2022 Q1	–	Sell	-20,000	Closed	-$686K	–	6990
2021 Q4	$686K	Buy	+20,000	New	+$805K	﹤0.01%	4763
2021 Q3	–	Sell	-205,000	Closed	-$15.1M	–	6849
2021 Q2	$15.1M	Buy	205,000 +103,000	+101%	+$10.3M	0.01%	1467
2021 Q1	$9.33M	Buy	+102,000	New	+$9.9M	0.01%	1864

Other funds holding CVAC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management's CVAC Position: Q4 2025 in Review

Millennium Management sold out of CureVac (CVAC) in Q4 2025, closing a stake of 41,804 shares — an estimated $225K sold.

Millennium Management first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $19.6M in Q2 2023. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Millennium Management reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Millennium Management sold 41,804 CureVac shares in Q4 2025, an estimated $225K.
Millennium Management first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
Millennium Management's CureVac position peaked at $19.6M in Q2 2023.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.